192 related articles for article (PubMed ID: 35060328)
1. Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease.
Chen W; Zhao L; Guo L; Zhao L; Niu H; Lian H; Dai H; Chen J; Wang C
Clin Respir J; 2022 Mar; 16(3):173-181. PubMed ID: 35060328
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series.
Barry KK; Plumptre I; Bazewicz CG; Green BP; Treat JR; Hughes M; Morel KD; Wiss K; Liang MG
Pediatr Dermatol; 2023 Jan; 40(1):90-95. PubMed ID: 36128651
[TBL] [Abstract][Full Text] [Related]
3. Bilateral lung transplantation for Castleman disease with end-stage bronchiolitis obliterans.
Yue B; Huang J; Jing L; Yu H; Wei D; Zhang J; Chen W; Chen J
Clin Transplant; 2022 Jan; 36(1):e14496. PubMed ID: 34590355
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
[TBL] [Abstract][Full Text] [Related]
5. Clinical Analysis of Unicentric Castleman's Disease with Paraneoplastic Pemphigus and Bronchiolitis Obliterans.
Zhen JF; Zhang L; Cao XX; Feng J; Zhou DB; Lin SB; Li J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):492-498. PubMed ID: 28877826
[TBL] [Abstract][Full Text] [Related]
6. Masked pemphigus among pediatric patients with Castleman's disease.
Han SP; Fu LS; Chen LJ
Int J Rheum Dis; 2019 Jan; 22(1):121-131. PubMed ID: 30411519
[TBL] [Abstract][Full Text] [Related]
7. [Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus].
Pan JX; Zhu SN; Li SL; Wang DX
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):981-990. PubMed ID: 36241242
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine.
Kuriyama K; Kitamura Y; Tsuji T; Nishikawa R; Nagata H; Ohshiro M; Sugitani M; Hirakawa Y; Matsumoto Y; Iwai T; Uchiyama H
Curr Probl Cancer; 2022 Apr; 46(2):100813. PubMed ID: 34844771
[TBL] [Abstract][Full Text] [Related]
9. Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Lee S; Yamauchi T; Ishii N; Hashimoto T; Kinoshita K; Imamura S; Kamiya K
Int J Hematol; 2017 Dec; 106(6):852-859. PubMed ID: 28791608
[TBL] [Abstract][Full Text] [Related]
10. Castleman disease of plasma cell type accompanied with bronchiolitis obliterans: a case report and review of the literature.
Zhu Q; Wang S
J Med Case Rep; 2023 Dec; 17(1):539. PubMed ID: 38082371
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans, Castleman's disease, and a bullous disease: pemphigus vulgaris or paraneoplastic pemphigus?
Pizarro A; García-Tobaruela A; Pinilla J
Hum Pathol; 1998 Jun; 29(6):657-8. PubMed ID: 9635692
[No Abstract] [Full Text] [Related]
12. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic pemphigus with bronchiolitis obliterans in a child.
Mar WA; Glaesser R; Struble K; Stephens-Groff S; Bangert J; Hansen RC
Pediatr Dermatol; 2003; 20(3):238-42. PubMed ID: 12787274
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.
Ouedraogo E; Gottlieb J; de Masson A; Lepelletier C; Jachiet M; Salle de Chou C; Galicier L; Bagot M; Chevret S; Bouaziz JD
J Am Acad Dermatol; 2019 Jun; 80(6):1544-1549. PubMed ID: 30981429
[TBL] [Abstract][Full Text] [Related]
15. Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans.
Hirano T; Higuchi Y; Yuki H; Hirata S; Nosaka K; Ishii N; Hashimoto T; Mitsuya H; Okuno Y
J Clin Exp Hematop; 2015; 55(2):83-8. PubMed ID: 26490520
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic pemphigus and fatal bronchiolitis obliterans associated with Castleman disease: Report of an autopsy case.
Sano Y; Kikuchi Y; Morita S; Oka T; Saito K; Takeda N; Terashima K; Toyota H; Uchida H; Watabe S; Numakura S; Miyoshi S; Nagase H; Kamata M; Tada Y; Uozaki H
Pathol Int; 2021 Feb; 71(2):170-172. PubMed ID: 33382501
[No Abstract] [Full Text] [Related]
17. Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
Gu L; Ye S
J Clin Rheumatol; 2019 Aug; 25(5):e77-e78. PubMed ID: 29389687
[No Abstract] [Full Text] [Related]
18. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour.
Kim SC; Chang SN; Lee IJ; Park SD; Jeong ET; Lee CW; Ahn CM; Anhalt GJ
Br J Dermatol; 1998 Apr; 138(4):667-71. PubMed ID: 9640377
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic pemphigus caused by pre-existing stroma-rich variant of Castleman disease: from a pathologist's point of view.
Gwiti P; Melegh Z; Johnston S; Sutak J
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975839
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment and prognosis analysis of localized retroperitoneal Castleman disease: a study of 20 cases].
Tang JQ; Yang YM; Xiong Y; Wan YL; Zhu XJ
Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(22):1685-8. PubMed ID: 20137716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
